Third, CEA is not necessarily utilized by pancreatic cancer cells as part of the malignant process, and it could be argued that gene products contributing to cancer cell growth or survival may be more desirable to target. The gene discussed is CEACAM5; the disease is familial pancreatic carcinoma.